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Introduction: Insomnia is a common problem among the people all over the world. 
This problem affects both sleep’s quantity and quality. Among sedative-hypnotic 
drugs, barbiturates are more toxic than benzodiazepines. Besides, current 
benzodiazepines have many side effects like dependence, muscle relaxation, and 
withdrawal syndrome. Attention to synthesize novel benzodiazepine like derivatives, 
which have fewer side effects, has been improved. Thiazolidinone derivatives are 
novel benzodiazepine-like compounds that have all pharmacophores like lipophilic 
group and aromatic ring for binding to the benzodiazepine receptor (GABA). 
Methods and Results: In this research hypnotic effect of two novel thiazolidinone 
derivatives were evaluated, using pentobarbital-induced loss of righting reflex test. 
Open field test, was used to evaluate the locomotor activity of the mice in all groups. 
Male mice in the range of 18-25 g of weight were used in all tests. Moreover, 
diazepam and flumazenil were used as an agonist and antagonist of GABA-A 
receptor respectively to indicate that the novel compounds show their effects through 
interacting with benzodiazepine receptors. Compound SM4 at the dose of 20, 30, 
and 40 mg/kg (i.p.) and compound SM6 at the dose of 30 and 40 mg/kg (i.p.) 
increased the sleeping time dose-dependently and showed significant hypnotic 
effects compared to the control group in the righting reflex test. Also, the sleeping 
time was decreased by the injection of flumazenil as an antagonist of GABA-A 
receptor after the injection of each compound. In the open field test, both compounds 
at the dose of 20, 30, and 40 mg/kg (i.p.) decreased the total distance moved which 
indicates sedative effect of the novel compounds. 
Conclusions:The results indicate that both compounds (SM4 and SM6) have 
sedative-hypnotic effects, which may be due to an interaction between novel 
benzodiazepine-like compounds and GABA-A receptor. We recommend further 
studies to determine the exact mechanism of action and toxicity of the novel 
compounds.  
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